The impact of migration on the sexual health, behaviours and attitudes of Central and East European gay/bisexual men in London by Mole, R, Parutis, V, Gerry, C, Burns, F

Migration and sexual resocialisation: the case of Central and East Europeans in London by Mole, R, Gerry, C, Parutis, V, Burns, F

How does online postal self-sampling (OPSS) shape access to testing for sexually transmitted infections (STIs)? A qualitative study of service users by Spence, T, Howarth, A, Reid, D, Sheringham, J, Apea, V, Crundwell, D, Day, S, Dewsnap, C, Jackson, L, Mercer, CH, Mohammed, H, Ross, JDC, Sullivan, A, Williams, A, Winter, A, Wong, G, Burns, F, Gibbs, J

HIV/HBV co-infection remodels the immune landscape and natural killer cell ADCC functional responses by Sun, B, da Costa, KAS, Alrubayyi, A, Kokici, J, Fisher-Pearson, N, Hussain, N, D’Anna, S, Piermatteo, L, Salpini, R, Svicher, V, Kucykowicz, S, Ghosh, I, Burns, F, Kinloch, S, Simoes, P, Bhagani, S, Kennedy, PTF, Maini, MK, Bashford-Rogers, R, Gill, US, Peppa, D

Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV by Alrubayyi, A, Gea-Mallorquí, E, Touizer, E, Hameiri-Bowen, D, Kopycinski, J, Charlton, B, Fisher-Pearson, N, Muir, L, Rosa, A, Roustan, C, Earl, C, Cherepanov, P, Pellegrino, P, Waters, L, Burns, F, Kinloch, S, Dong, T, Dorrell, L, Rowland-Jones, S, McCoy, LE, Peppa, D

Safety and efficacy of NVX-CoV2373 Covid-19 vaccine by Heath, PT, Galiza, EP, Baxter, DN, Boffito, M, Browne, D, Burns, F, Chadwick, DR, Clark, R, Cosgrove, C, Galloway, J, Goodman, AL, Heer, A, Higham, A, Iyengar, S, Jamal, A, Jeanes, C, Kalra, PA, Kyriakidou, C, McAuley, DF, Meyrick, A, Minassian, AM, Minton, J, Moore, P, Munsoor, I, Nicholls, H, Osanlou, O, Packham, J, Pretswell, CH, San Francisco Ramos, A, Saralaya, D, Sheridan, RP, Smith, R, Soiza, RL, Swift, PA, Thomson, EC, Turner, J, Viljoen, ME, Albert, G, Cho, I, Dubovsky, F, Glenn, G, Rivers, J, Robertson, A, Smith, K, Toback, S

Safety and efficacy of the NVX-CoV2373 coronavirus disease 2019 vaccine at completion of the placebo-controlled phase of a randomized controlled trial by Heath, PT, Galiza, EP, Baxter, DN, Boffito, M, Browne, D, Burns, F, Chadwick, DR, Clark, R, Cosgrove, CA, Galloway, J, Goodman, AL, Heer, A, Higham, A, Iyengar, S, Jeanes, C, Kalra, PA, Kyriakidou, C, Bradley, JM, Munthali, C, Minassian, AM, McGill, F, Moore, P, Munsoor, I, Nicholls, H, Osanlou, O, Packham, J, Pretswell, CH, San Francisco Ramos, A, Saralaya, D, Sheridan, RP, Smith, R, Soiza, RL, Swift, PA, Thomson, EC, Turner, J, Viljoen, ME, Fries, L, Cho, I, McKnight, I, Glenn, G, Rivers, EJ, Robertson, A, Alves, K, Smith, K, Toback, S